Oct. 27, 2025 — The American Heart Association (Association) has launched its latest professional certification program ...
Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...
Oct. 21, 2025 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...
Oct. 22, 2025 — Qure has announced its latest (510) K clearance from the US Food and Drug Administration (FDA). The ...
Oct. 22, 2025 — Nyra Medical, a leading innovator in structural heart therapies, has announced the initiation of its ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 22, 2025 — Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible ...
Oct. 21, 2025 — Early and accurate detection of heart rhythm problems can mean the difference between life-saving ...
Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Oct. 21, 2025 — GE HealthCare has received CE mark for its Carevance patient monitor, advancing accessible and reliable ...
Oct. 21, 2025 — At the seventeenth edition of the World Stroke Congress in Barcelona, Siemens Healthineers will present ...
Oct. 20, 2025 – Brainomix, a provider of AI-powered imaging tools in lung fibrosis and stroke, will present new evidence ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Oct. 16, 2025 — Thirona recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...
Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...
Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...
October 27, 2025
